Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,812 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study.
Shizuta S, Ando K, Nobuyoshi M, Ikeda T, Yoshino H, Hiramatsu S, Kazatani Y, Yamashiro K, Okajima K, Kajiya T, Kobayashi Y, Kato T, Fujii S, Mitsudo K, Inoue K, Ito H, Haruna Y, Doi T, Nishio Y, Ozasa N, Nishiyama K, Kita T, Morimoto T, Kimura T; PREVENT-SCD Investigators. Shizuta S, et al. Among authors: ikeda t. Clin Res Cardiol. 2012 Feb;101(2):89-99. doi: 10.1007/s00392-011-0368-2. Epub 2011 Sep 30. Clin Res Cardiol. 2012. PMID: 21960418 Free PMC article.
Comparison of late potentials for 24 hours between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy using a novel signal-averaging system based on Holter ECG.
Abe A, Kobayashi K, Yuzawa H, Sato H, Fukunaga S, Fujino T, Okano Y, Yamazaki J, Miwa Y, Yoshino H, Ikeda T. Abe A, et al. Among authors: ikeda t. Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):789-95. doi: 10.1161/CIRCEP.111.969865. Epub 2012 Jun 4. Circ Arrhythm Electrophysiol. 2012. PMID: 22665699
Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
Kinoshita T, Ishikawa Y, Arita M, Akishima-Fukasawa Y, Fujita K, Inomata N, Suzuki T, Namiki A, Mikami T, Ikeda T, Yamazaki J, Ishii T, Akasaka Y. Kinoshita T, et al. Among authors: ikeda t. Cardiovasc Pathol. 2014 Mar-Apr;23(2):92-100. doi: 10.1016/j.carpath.2013.11.001. Epub 2013 Nov 14. Cardiovasc Pathol. 2014. PMID: 24322055
Present profiles of novel anticoagulant use in Japanese patients with atrial fibrillation: insights from the Rivaroxaban Postmarketing Surveillance Registry.
Ogawa S, Ikeda T, Kitazono T, Nakagawara J, Minematsu K, Miyamoto S, Murakawa Y, Iekushi K, Yamanaka S, Yamada T, Inuyama L; Rivaroxaban PostMarketing Surveillance Registry Investigators. Ogawa S, et al. Among authors: ikeda t. J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2520-2526. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.006. Epub 2014 Sep 20. J Stroke Cerebrovasc Dis. 2014. PMID: 25245483
Early-Morning Type Ventricular Fibrillation With J Wave.
Fujino T, Yamazaki Y, Tsubota T, Ikeda T. Fujino T, et al. Among authors: ikeda t. Int Heart J. 2015;56(4):459-61. doi: 10.1536/ihj.14-394. Epub 2015 Jun 18. Int Heart J. 2015. PMID: 26084458 Free article.
6,812 results